Atripla Adherence and Resistance Relationships [I]

Investigator: Steven Deeks, MD
Sponsor: Gilead Sciences, Inc.

Location(s): United States


50 patients initiating or switching to Atripla are compared to 250 individuals previously followed in a prospective study of HIV+ low income individuals recruited from homeless shelters, single room occupancy hotels and free meal food lines as part of the UCSF Reach Study. Adherence is measured through monthly unannounced pill counts and electronic medication monitors.